AMLX - Company ID 0001658551
As of 2026-09-07, Amylyx Pharmaceuticals, Inc. (AMLX) has a market capitalization of $3.79 B, making it the #1649 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-07 | $3.79 B |
| 2026-09-06 | $3.79 B |
| 2026-09-05 | $3.79 B |
| 2026-09-04 | $3.79 B |
| 2026-09-03 | $3.79 B |
| 2026-09-02 | $3.83 B |
| 2026-09-01 | $3.76 B |
| 2026-08-31 | $3.75 B |
| 2026-08-30 | $3.86 B |
| 2026-08-29 | $3.86 B |
| 2026-08-28 | $3.86 B |
| 2026-08-27 | $4.13 B |
As of 2026-09-07, Amylyx Pharmaceuticals, Inc. (AMLX) has a market capitalization of $3.79 B, making it the #1649 most valuable US-listed company.
Amylyx Pharmaceuticals, Inc. is the #1649 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-26 | $4.07 B |
| 2026-08-25 | $4.17 B |
| 2026-08-24 | $4.24 B |
| 2026-08-23 | $4.30 B |
| 2026-08-22 | $4.30 B |
| 2026-08-21 | $4.30 B |
| 2026-08-20 | $4.41 B |
| 2026-08-19 | $4.29 B |
| 2026-08-18 | $3.90 B |
| 2026-08-17 | $2.38 B |
| 2026-08-16 | $2.40 B |
| 2026-08-15 | $2.40 B |
| 2026-08-14 | $2.40 B |
| 2026-08-13 | $2.52 B |
| 2026-08-12 | $2.60 B |
| 2026-08-11 | $2.63 B |
| 2026-08-10 | $2.52 B |
| 2026-08-09 | $2.54 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.